These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33380663)

  • 21. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma.
    Karabulut S; Afsar CU; Karabulut M; Alis H; Bozkurt MA; Aydogan F; Serilmez M; Tas F
    BBA Clin; 2016 Dec; 6():138-142. PubMed ID: 27785418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer.
    Shi W; Lu Y; Gong R; Sun JJ; Liu G
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis.
    Menadi S; Kucuk B; Cacan E
    Biochem Genet; 2024 Aug; 62(4):2721-2742. PubMed ID: 38001391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Zhang W; Gao C; Zhang S; Fang G
    J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.
    Aoki S; Motoi F; Murakami Y; Sho M; Satoi S; Honda G; Uemura K; Okada KI; Matsumoto I; Nagai M; Yanagimoto H; Kurata M; Fukumoto T; Mizuma M; Yamaue H; Unno M;
    BMC Cancer; 2019 Mar; 19(1):252. PubMed ID: 30898101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and diagnostic significance of annexin A2 in colorectal cancer.
    Yang T; Peng H; Wang J; Yang J; Nice EC; Xie K; Huang C
    Colorectal Dis; 2013 Jul; 15(7):e373-81. PubMed ID: 23489866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.
    Foley K; Rucki AA; Xiao Q; Zhou D; Leubner A; Mo G; Kleponis J; Wu AA; Sharma R; Jiang Q; Anders RA; Iacobuzio-Donahue CA; Hajjar KA; Maitra A; Jaffee EM; Zheng L
    Sci Signal; 2015 Aug; 8(388):ra77. PubMed ID: 26243191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer.
    He XY; Liu BY; Yao WY; Zhao XJ; Zheng Z; Li JF; Yu BQ; Yuan YZ
    J Dig Dis; 2011 Apr; 12(2):131-7. PubMed ID: 21401899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
    Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
    J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma.
    Tas F; Karabulut S; Bilgin E; Sen F; Yildiz I; Tastekin D; Ciftci R; Duranyildiz D
    Tumour Biol; 2013 Dec; 34(6):3529-36. PubMed ID: 23784459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
    Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM
    PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
    Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
    Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    Uesato Y; Sasahira N; Ozaka M; Sasaki T; Takatsuki M; Zembutsu H
    PLoS One; 2020; 15(7):e0235623. PubMed ID: 32614932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
    Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
    World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
    Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
    J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis.
    Liu Z; Ling Q; Wang J; Xie H; Xu X; Zheng S
    Oncol Lett; 2013 Jul; 6(1):125-129. PubMed ID: 23946789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression.
    Abdelraouf EM; Hussein RRS; Shaaban AH; El-Sherief HAM; Embaby AS; Abd El-Aleem SA
    Life Sci; 2022 Nov; 308():120967. PubMed ID: 36116530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer.
    Cetin S; Dede I
    J Cancer Res Ther; 2020; 16(4):909-916. PubMed ID: 32930139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.